Skip to content

To evaluate clinical outcomes and patient satisfaction with Trifocal Intraocular lens

A Prospective, Single arm, post-marketing clinical study to assess visual performance and safety of OPTIFLEX TRIO Intraocular lens following bilateral implantation. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061967
Enrollment
54
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: OPTIFLEX TRIO Intraocular lens: OPTIFLEX TRIO Intraocular Lenses (IOLs) are Trifocal hydrophobic aspheric foldable single piece posterior chamber IOLs. These IOLs are designed to be sur

Sponsors

Tirupati Eye Centre and research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patient, 18 years old or older will be enrolled in the study 2. Patient with cataract 3. Calculated IOL power is within the range of the investigational IOL 4. Patients must sign and be given a copy of the written Informed Consent form 5. Clear intraocular media other than cataract 6. Patient willing to undergo the investigations and comply with the follow-up schedule 7. Female participants of child bearing potential and male participants whose partner is of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study

Exclusion criteria

Exclusion criteria: 1. Previous intraocular or corneal surgery 2. Traumatic cataract 3. Pregnancy or lactation 4. Concurrent participation in another drug or device investigation 5. Instability of keratometry or biometry measurements 6. Irregular astigmatism 7. More than 1 D of pre-operative corneal astigmatism

Design outcomes

Primary

MeasureTime frame
Uncorrected Intermediate Visual Acuity (UIVA) (Photopic) Timepoint: Post-operative: 120-180 days

Secondary

MeasureTime frame
Visual Acuity, Subjective Refraction,Intraocular Pressure, Keratometry, Corneal Status, Signs of InflammationTimepoint: [Time Frame: Pre-operative, Postoperative 1-2 days, 7-14 days, 30-60 days, 120-180 days and 330-420 day]

Countries

India

Contacts

Public ContactDr Mohita Sharma

Tirupati Eye Centre and research Institute

drmohita@tirupatieye.org9971308775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026